Document is current
Any future updates will be listed below
-
Authors
Casas Deza, Diego
Julián Gomara, Ana Belén
Caudevilla Biota, Eva
Beltrán, Belén
Domènech, Eugeni
Gutiérrez Casbas, Ana
Mañosa, Miriam
Zabana, Yamile
Roc Alfaro, Lourdes
Valverde Romero, Emilio
García González, Elena
Sicilia, Beatriz
Laredo, Viviana
Alcalá Escriche, Maria José
Madero Velázquez, Lucia
Ferreiro-Iglesias, Rocío
Palmero Pérez, Antonia
Calafat, Margalida
Rubio Iturria, Saioa
Moraleja Yudego, Irene
Ber Nieto, Yolanda
García Mateo, Sandra
Gisbert, Javier P.
Vicente Lidón, Raquel
Arias, Lara
Alfambra, Erika
Doñate Borao, Ana Belén
Peña González, Elena
Corsino Roche, Pilar
Vicuña Arregui, Miren
Elorza, Ainara
Domínguez Cajal, Manuel
Chaparro, María
Barreiro-de Acosta, Manuel
García-López, Santiago
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (CM21/00067)
Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study)
Journal Title: Gastroenterología y Hepatología
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastrohep.2023.11.004
Content Type: article
Copyright: © 2023 Elsevier España, S.L.U. All rights reserved.
